Ingredients and flavours strong for Kerry within ‘stable, unsurprising’ results

By Kacey Culliney

- Last updated on GMT

Kerry Group 2011 revenue pegged at €5.3bn
Kerry Group 2011 revenue pegged at €5.3bn
Favourable consumer trends for healthy formulations and natural flavours ensured steady growth in the ingredients and flavours segment of Kerry Group.

In results published today, the Ireland-headquartered company pegged its 2011 earnings at €5.3bn, with a ‘milestone’ trading profit of €501m and an overall earnings growth of 6.9% for 2011.

It detailed a steady performance in its ingredients and flavours division, pegged at €3,706m with a 7.7% LFL (like-for-like) growth for 2011 and weaker results for its consumer products business, valued at €1,674m with just a 3.2% LFL growth.

Consumer trends for natural flavours and healthier formulations favour our technologies, Frank Hayes, director of corporate affairs, told

“Our ingredients and flavours business has the broadest range and greatest depth of technologies that can meet consumer requirements,”​ Hayes said.

The group’s 2011 performance delivered on objectives set despite the continuing economic challenges, he said, referencing high raw material costs, input cost inflation and weak consumer confidence.

Joe Gill, a broker with Dublin-based Bloxham Stockbrokers, said that the results while very assuring, feature no major positives or negatives and are not surprising, just steady.

“Stable growth has been the pattern of Kerry for many years. It believes in a steady growth of between 8-12% a year and so the company is very pleased with these results,” ​Gill said.

‘Solid’ ingredients and flavours performance

Takings grew across all technology sectors within the ingredients and flavours business arm with beverage systems performing strongest with a 12.6% growth, followed by pharmaceutical, nutritional and functional ingredients (9.1%), savoury and dairy systems (7.9%) and cereal and sweet systems (5.4%).

The group said that innovation continues within this sector driven by consumer demand for ‘free-from foods’, reduced fats and salts, naturals and enhanced dietary and nutritional products.

James Targett, senior analyst at private banking firm Berenberg Bank, said that increased consumer demand for reformulation is driving growth in the ingredients and flavours segment of Kerry Group.

He noted the segment saw a “very solid performance… with a strong underlying growth and resilient margins.”

Changing growth strategies

In December Kerry purchased Cargill’s global flavours unit for €170m (US$230m) marking part of the group’s wider growth strategy and dedication to flavours and food ingredients.

A total of €386.4m was pumped into acquisitions in 2011, but Gill said fewer funds will be committed to external growth in 2012.

“Despite the group having the fire power to do so, I’d assume that the focus will be on internal growth instead of acquisitions in 2012… I would imagine the spend [on acquisitions] will be closer to €250m, so slightly less,” ​Gill said.

However, Kerry today confirmed the completed acquisition of South African flavours company FlavourCraft for an undisclosed sum, a move it said signalled its commitment to expansion across the African continent.

FlavourCraft specialises in the development of flavours for meats, soups, sauces, dressings and savoury snacks in the South African and sub-Saharan markets, particularly Nigeria.

In the annual figures released today, the largest sales growth for 2011 was realised in the Asia Pacific region, with a 12% LFL growth driving revenues to €605m and a business volume growth of 10%.

EMEA (Europe, the Middle East and Africa) sales were pegged at €1,475m with revenues from the Americas pulling in just over at €1,558m.

Related news

Related products

show more

INNOBIO® Vegan EAAs Enhanced with Vegan CLA

INNOBIO® Vegan EAAs Enhanced with Vegan CLA

INNOBIO Limited | 19-Aug-2019 | Technical / White Paper

It is known to all that EAAs can improve muscle growth and exercise performance, as well as increase lean body mass and prevent muscle loss. INNOBIO® EAAs...

Fermented Soy for Natural Digestive Support

Fermented Soy for Natural Digestive Support

Lallemand Bio-Ingredients | 22-Apr-2019 | Technical / White Paper

Lallemand is running a new clinical trial for Gastro-AD® in spring 2019. Gastro-AD® is a clinically studied food supplement based on non-GMO soy fermented...

Discover the Significance of sIgA for Immunity

Discover the Significance of sIgA for Immunity

LEHVOSS Nutrition– Gee Lawson | 28-Mar-2019 | Technical / White Paper

Embria Health Science’s dietary supplement ingredient EpiCor® fermentate has been shown in multiple published human clinical trials to help strengthen...

Related suppliers

Follow us

Featured Events

View more


View more